-
Security Type
-
Common Stock
-
Min Investment
-
$99
-
Offering Date
-
January 29, 2021
-
Expected Close Date
-
March 30, 2021
-
Target Raise
-
$10.00K-$1.00M
-
Deal Notes
-
Price per Share: $0.10
-
Valuation
-
$10,287,000
Company Description
Eyes 4 Lives has developed a unique yet effective AI software solution to minimize/prevent Digital Eye Strain (DES), a group of eye and vision-related problems caused by our addiction to cell phones, tablets, and computers. DES is currently affecting about 65% of the Americans and is one of the hottest topics in the eye care and ergonomic industries, particularly during the COVID-19 pandemic when just about everyone is staring at the electronic screens to work/learn remotely.
Key Deal Facts
First mover advantage, R&D led to extensive patent portfolio
Raised 2.8M seed from friend, family and patients
Developed, produced and sold generation 1 external device.
Successful small-scale clinical efficacy study at USC (10 participants).
Pivoted to embedded cameras and utilizing advanced AI let to collaboration with:MOU with Intel CorporationR&D collaboration with world’s largest TV manufacturerLOI with Quanta Computer
MOU with Intel Corporation
R&D collaboration with world’s largest TV manufacturer
LOI with Quanta Computer
2019 CES showcase with Quanta Computer
2021 CES showcase with Intel demoing E4L software on their latest platform
Use of Proceeds
- Compensation for managers
- Software Development/Optimization
- Patent Expansion/enforcement
- Efficacy Study
- Intermediary fees
Management Team / Advisory Board Bios
Roger L. Wu, O.D.
Founder & CEO
Over 23 years of experience as an Optometrist
10 years research on Computer Vision Syndrome
Keynote Speaker at NASA, National Ergonomic Council and ErgoExpo2018 on Digital Eye Strain
First optometric intern selected for the 1996 Summer Olympic Games in Atlanta
Doctor of Optometry, Pennsylvania College of Optometry